by Mojgan Hosseinipour, DO on
Acne is the most common skin condition in the United States. Although it affects almost 50 million individuals annually, how it affects each person varies. Many epidemiologic studies have shown that acne is the most common presenting complaint in patients with Fitzpatrick skin types IV-VI. However, post-inflammatory hyperpigmentation is a common sequela of acne in patients of skin of color and a p …
by Nicole Negbenebor, MD on
At the 17th Annual ODAC Dermatology, Aesthetic & Surgical Conference held in Orlando, Florida, Dr. Linda Stein Gold, Director of Dermatology Clinical Research and Division Head of Dermatology for the Henry Ford Health System, lectured on new and future treatments for acne. She opened her lecture by describing the traditional view of lesion progression in acne vulgaris, where the microcomedone …
by NEXT STEPS IN DERM TEAM on
In addition to gentle washing of the face two times a day, what is the most appropriate treatment step for this patient who is prone to dry skin?
A. Start Adapalene 0.1 gel nightly to every other night after wash
B. Aggressive exfoliation daily
C. Start doxycycline 100 mg by mouth two times a day with food and water
D. Monotherapy with clindamycin lotion every morning after wash
by Angelo Landriscina, MD on
In the newest installment of our Therapeutic Cheat Sheet series, we turn to the treatment of acne. Mutli-mechanistic approaches result in improved outcomes for patients, especially when it comes to the multifactorial causes of acne. Adapalene 0.3%-benzoyl peroxide 2.5% gel (also known as Epiduo Forte) provides a useful tool for delivering two mainstays of acne therapy in one topical agent.